Biosimilar User Fee Act Research Grant Clinical Trials Optional

Biosimilar User Fee Act Research Grant Clinical Trials Optional

Budget is limited to $5 million - Expiry date is May 10, 2022

U.S. Food & Drug Administration
The Food and Drug Administration (FDA) protects the public health by ensuring that pharmaceutical drug products intended to be marketed in the United States are safe and effective for their intended use...

Funding Opportunity

Visit the funding page (members only, sign in): Biosimilar User Fee Act Research Grant Clinical Trials Optional

Sign in or register for free to read the full details and apply

Sign in Create a free account

Share:

All funding opportunities